Abstract
Objectives:To identify psychiatric differences between patients with chronic fatigue and those with rheumatoid arthritis and to investigate whether patients meeting Centers for Disease Control (CDC) criteria for chronic fatigue syndrome (CFS) can be differentiated from patients with chronic fatigue on measures of disability and psychosocial distress.
Design:Cross-sectional study comparing 98 patients with chronic fatigue with 31 patients with rheumatoid arthritis on structured psychiatric interviews and patient questionnaires. Nineteen patients meeting CDC criteria for CFS were compared with 79 patients with chronic fatigue not meeting CDC criteria on questionnaires measuring disability and psychosocial distress.
Setting:Consecutive patients with chronic fatigue were selected from a chronic fatigue clinic at the University of Washington, and 31 consecutive patients with rheumatoid arthritis were sampled from a private rheumatology practice.
Main results:Patients with chronic fatigue had a significantly higher prevalence of lifetime major depression and somatization disorder than did patients with rheumatoid arthritis. Patients with chronic fatigue also had a significantly higher prevalence of current and lifetime psychiatric diagnoses. Only 19 of 98 patients with chronic fatigue met CDC criteria for CFS. Patients meeting CDC criteria for CFS could not be differentiated from the larger group of patients with chronic fatigue on any study variable.
Conclusions:Patients with chronic fatigue have a significantly higher burden of psychiatric illness than do patients with rheumatoid arthritis. The psychiatric illness preceded the development of chronic fatigue in over half the patients. Centers for Disease Control criteria for CFS did not select a subset of chronic fatigue patients who could be differentiated on disability or psychosocial parameters from patients with chronic fatigue who did not meet CDC criteria.
Similar content being viewed by others
References
The National Ambulatory Medical Care Survey: 1975 summary. Hyattsville, MD: National Center for Health Statistics, 1978;22–6.
Kroenke K, Wood DR, Mangelsdorff AD. Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA. 1988;260:929–34.
Buchwald D, Sullivan JL, Komaroff A. Frequency of “chronic active Epstein-Barr virus infection” in a general medical practice. JAMA. 1987;257:2303–8.
The Health and Lifestyle Survey [British government study]. Health Promotion Research Trust, 1987.
Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working definition. Ann Intern Med. 1988;108:387–9.
Straus S. The chronic mononucleosis syndrome. J Infect Dis. 1988;157:405–12.
Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause? JAMA. 1987;257:2247–302.
Gold D, Bowden R, Sixbey J, et al. Chronic fatigue: a prospective clinical and virologic study. JAMA. 1990;264:48–53.
Manu P, Matthews DA, Lane TJ. The mental health of patients with a chief complaint of chronic fatigue: a prospective evaluation and follow-up. Arch Intern Med. 1988;148:2213–7.
Wessely S, Powell R: Fatigue syndromes: a comparison of chronic “postviral” fatigue with neuromuscular and affective disorder. J Neurol Neurosurg Psychiatry. 1989;52:940–8.
Taerk GS, Toner BB, Salit IE, et al. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis). Int J Psychiatry Med. 1987;13:49–52.
Kruesi MJP, Dale J, Straus S. Psychiatric diagnoses in patients who have chronic fatigue. J Clin Psychiatry. 1989;50:53–6.
Arnett FC, Edworthy SM, Block DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–23.
Robins LN, Helzer JE. Diagnostic Interview Schedule (DIS): Version III-A. St. Louis, MO: Department of Psychiatry, Washington University School of Medicine, 1985.
American Psychiatric Association Diagnostic and statistical manual of mental disorders (third edition—revised) DSM-III-R. Washington, DC: APA, 1987.
Von Korff MR, Anthony JC. The Diagnostic Interview Schedule modified to record current mental status. J Affective Disord. 1982;4:369–71.
Zimmerman M, Coryell W, Corenthal C. A self-report scale to diagnose major depressive disorder. Arch Gen Psychiatry. 1986;43:1076–81.
Stewart A, Hays RD, Ware J. The MOS Short-Form General Health Survey. Med Care. 1988;26:724–35.
Main CJ. The Modified Somatic Perception Questionnaire (MSPQ). J Psychosom Res. 1983;27:503–14.
Goldberg D. The detection of psychiatric illness by questionnaire. London: Oxford University Press, 1972.
Bridges KW, Goldberg DP. The validation of the GHQ-28 and the use of the MMSE in neurologic inpatients. Br J Psychiatry. 1986;148:548–53.
Pennebaker JW. The psychology of physical symptoms. New York: Springer, Verlag, 1982.
Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659–62.
Wells K, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914–9.
Manu P, Lane TJ, Matthews DA. The frequency of chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann Intern Med. 1988;109:554–6.
Kiecolt-Glaser JK, Glaser R, Shuttleworth EC. Chronic stressed immunity in family care-givers of Alzheimer’s disease victims. Psychosom Med. 1987;49:523–35.
McKinnon W, Weisse CS, Reynolds CF, Bowles CA, Baum A. Chronic stress, leukocyte subpopulations, and humoral response to latent viruses. Health Psychol. 1989;8:389–402.
Calabrese JR, Kling MA, Gold PW. Alterations in immunocompetence during stress, bereavement and depression: focus on neuroendocrine regulation. Am J Psychiatry. 1987;144:1123–33.
Depression, stress and immunity [editorial]. Lancet. 1987;i:1467–8.
Imboden JB, Canter A. Convalescence from influenza: a study of the psychological and clinical determinants. Arch Intern Med. 1961;108:393–9.
Regier DA, Hirschfeld RMA, Goodwin FK, et al. The NIMH depression awareness, recognition and treatment program: structure, aims and scientific basis. Am J Psychiatry. 1988;145:1351–7.
Bridges KW, Goldberg DP. Somatic presentation of DSM-III psychiatric disorder in primary care. J Psycholsom Res. 1985;29:563–9.
Matthew RJ, Weinman ML, Mirabi M. Physical symptoms of depression. Br J Psychiatry. 1981;139:293–6.
Waxman HM, McCreary G, Weinrit RM, Carner EA. A comparison of somatic complaints among depressed and nondepressed older persons. Gerontologist. 1985;24:501–7.
Katon W, Russo J. Somatic symptoms and depression. J Fam Pract. 1989;29:65–9.
Escobar JI, Burnham MA, Karno M, et al. Somatization in the community. Arch Gen Psychiatry. 1987;44:713–8.
Katon WJ, Hall JL, Russo J, et al. Chest pain: relationship of psychiatric illness to coronary arteriographic results. Am J Med. 1988;84:1–9.
Walker EA, Katon WJ, Harrop-Griffiths J, et al. Relationship of chronic pelvic pain to psychiatric diagnoses and childhood sexual abuse. Am J Psychiatry. 1988;45:75–80.
Katon WJ, Eagn K, Miller D. Chronic pain: lifetime psychiatric diagnoses and family history. Am J Psychiatry. 1985;142:1156–60.
Walker EA, Roy-Byrne PP, Katon W. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry. 1990;147:1656–61.
Pennebaker JW. The psychology of physical symptoms. New York: Springer, Verlag, 1982.
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA. 1989;262:1479–84.
Katon W, Von Korff M, Lin E, et al. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry. 1990;12:355–62.
Adams RD, Victor M. Viral infections of the nervous system. In: Principles of neurology, third edition. San Francisco: McGraw Hill, 1985;545–68.
Bluestein HG. Neuropsychiatric manifestations of systemic lupus erythematosis. N Engl J Med. 1987;317:309–11.
McConald EM, Mann AH, Thomas HC. Interferons as mediators of psychiatric morbidity. Lancet. 1987;ii:1175–7.
Wallace DJ, Margolin K, Waller P. Fibromyalgia and interleukin-2 theory for malignancy. Ann Intern Med. 1988;109:909.
Denicoff K, Rubinow DR, Pap MZ, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 1987;107:293–300.
Katon W, Roy-Byrne PP. Antidepressants in the mekdically ill. Clin Chem. 1989;34:829–36.
Katon W, Roy-Byrne PP. Panic disorder in the medically ill. J Clin Psychiatry. 1989;50:299–302.
Author information
Authors and Affiliations
Additional information
Supported by a grant from NARSAD.
Rights and permissions
About this article
Cite this article
Katon, W.J., Buchwald, D.S., Simon, G.E. et al. Psychiatric Illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med 6, 277–285 (1991). https://doi.org/10.1007/BF02597420
Issue Date:
DOI: https://doi.org/10.1007/BF02597420